Device Cardiovascular Products

Herc Flex Universal Stabilizer Arm

Payments companies reported to CMS as associated with Herc Flex Universal Stabilizer Arm. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$11Kassociated payments (2023-2025)
87clinicians with associated payments
1company reporting

By year

2023 $8,831
2024 $982
2025 $1,392

Payments reported as associated with Herc Flex Universal Stabilizer Arm, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Thoracic Surgery (Cardiothoracic Vascular Surgery) $3,193
Physician Assistant $1,336
Surgical $920
Anesthesiology $192
Nurse Anesthetist, Certified Registered $92.86
Nurse Practitioner $52.94

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Herc Flex Universal Stabilizer Arm

These are the largest totals companies reported as associated with Herc Flex Universal Stabilizer Arm. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Hiroyuki Tsukui Pittsburgh, PA Thoracic Surgery (Cardiothoracic Vascular Surgery) $2,296.32
James Martin Warren, MI Thoracic Surgery (Cardiothoracic Vascular Surgery) $204.76
Thuy Le Ann Arbor, MI Physician Assistant $155.58
Jeffrey Schneider Ann Arbor, MI Physician Assistant $155.58
Joseph Allgeyer Ann Arbor, MI Physician Assistant $155.58
Teimour Nasirov Palo Alto, CA Thoracic Surgery (Cardiothoracic Vascular Surgery) $143.78
Michael Leininger Joliet, IL Physician Assistant $114.06
Anamaria Edwards Maywood, IL Physician Assistant $114.06
Brittany Waclaw Chicago, IL Surgical $114.06
Abigail Berger Downers Grove, IL Surgical $114.06

Prescribed Herc Flex Universal Stabilizer Arm?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.